Sanofi and Advent finalise negotiations for the acquisition of Zentiva

Sanofi and Advent International (Advent) have finished negotiations for the acquisition of Zentiva - Sanofi's European generics business. Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion...

Takeda ups bid to $65 billion in negotiations to buy Shire

Takeda has increased offer to buy Shire for a mix of stock and cash worth ~$65 billion

Merck to sell Consumer Health to Procter & Gamble

Merck has sold its global Consumer Health business to Procter & Gamble

Advent in negotiations to acquire Sanofi’s generics business

Advent and Sanofi are in negotiations under which Advent would acquire Zentiva,

Certara acquires Analytica Laser

Certara announced it has acquired Analytica Laser which uses health economics and outcomes research (HEOR)

Mylan partners with Fujifilm Kyowa Kirin Biologics

Mylan partners with Fujifilm Kyowa Kirin Biologics to commercialise a biosimilar to Humira®

GSK buys out Novartis’ stake in Consumer Healthcare

GlaxoSmithKline plc have announced that it has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint...

Nanologica & Sterling partnership furthers new business venture

Nanologica AB has entered into a service agreement with global contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions for the large-scale production of...

Evotec & Sanofi in talks to create open innovation R&D platform

Evotec and Sanofi enter into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform in France In...

GSK buys out Novartis’ stake in Consumer Healthcare

GSK Announce agreement with Novartis for the buyout of their Consumer Healthcare

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...